Related Experiment Video
Updated: Dec 31, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
Overcoming Physiological Barriers to Nanoparticle Delivery-Are We There Yet?
Oliver S Thomas1,2,3, Wilfried Weber1,2,3
1Faculty of Biology, University of Freiburg, Freiburg, Germany.
Nanoparticle drug delivery systems face biological barriers, but engineering strategies can improve therapeutic efficacy for diseases like cancer. Overcoming these challenges maximizes nanomedicine
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Pharmacology
Background:
- Nanosized materials are clinically used for therapeutic agent delivery, with significant potential for treating various diseases.
- Nanomedicine, particularly in cancer treatment, requires overcoming physiological barriers for effective drug delivery.
Purpose of the Study:
- To review the physiological barriers encountered by nanocarriers during therapeutic delivery.
- To discuss strategies for engineering nanoparticles to enhance drug delivery efficiency, focusing on cancer nanomedicine.
Main Methods:
- Review of existing literature on nanoparticle delivery systems and physiological barriers.
- Analysis of nanoparticle behavior in the bloodstream, tumor microenvironment, and cellular uptake.
- Discussion of nanoparticle engineering strategies, including surface modification and targeting.
Main Results:
- Key delivery stages include bloodstream circulation, enhanced permeability and retention (EPR) effect-based accumulation, intratumoral diffusion, cellular uptake, and target site arrival.
- Strategies like PEGylation increase circulation half-life, but limitations and alternatives are being explored.
- Targeting and controlled activation approaches are crucial for efficient nanomedicine.
Conclusions:
- Overcoming physiological barriers is critical for realizing the full potential of nanomedicine.
- Continued advancements in nanoparticle engineering are essential for improving therapeutic outcomes in diseases like cancer.
Related Concept Videos
Factors Affecting Drug Distribution: Physiological Barriers
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
Bioavailability Enhancement: Drug Permeability Enhancement
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Physiological Barriers
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
Cellular Membranes and Drug Transport
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.

